Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mildvan

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
JAMA|September 11, 1987
Suramin therapy in AIDS and related disorders. Report of the US Suramin Working GroupB D Cheson, A M Levine, D Mildvan, et al.
NIDA Research Monograph|January 1, 1986
A stage model of HTLV-III LAV infection in intravenous drug usersD C Des Jarlais, S R Friedman, T J Spira, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the diseaseS Zolla-Pazner, D C Des Jarlais, S R Friedman, et al.
The Journal of Infectious Diseases|August 1, 1990
Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USAH H Lee, S H Weiss, L S Brown, et al.
Lancet (London, England)|May 12, 1984
Longitudinal study of persistent generalised lymphadenopathy in homosexual men: relation to acquired immunodeficiency syndromeU Mathur-Wagh, R W Enlow, I Spigland, et al.
HIV Medicine|January 21, 2004
Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patientsL Al-Harthi, J Voris, B K Patterson, et al.
JAMA|February 17, 1989
HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987D C Des Jarlais, S R Friedman, D M Novick, et al.
JAMA|November 3, 1989
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working GroupM A Fischl, D D Richman, D M Causey, et al.
The New England Journal of Medicine|July 23, 1987
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialM A Fischl, D D Richman, M H Grieco, et al.
The New England Journal of Medicine|July 23, 1987
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialD D Richman, M A Fischl, M H Grieco, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
JAMA|September 11, 1987
Suramin therapy in AIDS and related disorders. Report of the US Suramin Working GroupB D Cheson, A M Levine, D Mildvan, et al.
NIDA Research Monograph|January 1, 1986
A stage model of HTLV-III LAV infection in intravenous drug usersD C Des Jarlais, S R Friedman, T J Spira, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the diseaseS Zolla-Pazner, D C Des Jarlais, S R Friedman, et al.
The Journal of Infectious Diseases|August 1, 1990
Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USAH H Lee, S H Weiss, L S Brown, et al.
Lancet (London, England)|May 12, 1984
Longitudinal study of persistent generalised lymphadenopathy in homosexual men: relation to acquired immunodeficiency syndromeU Mathur-Wagh, R W Enlow, I Spigland, et al.
HIV Medicine|January 21, 2004
Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patientsL Al-Harthi, J Voris, B K Patterson, et al.
JAMA|February 17, 1989
HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987D C Des Jarlais, S R Friedman, D M Novick, et al.
JAMA|November 3, 1989
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working GroupM A Fischl, D D Richman, D M Causey, et al.
The New England Journal of Medicine|July 23, 1987
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialM A Fischl, D D Richman, M H Grieco, et al.
The New England Journal of Medicine|July 23, 1987
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialD D Richman, M A Fischl, M H Grieco, et al.
Pageof 9